Stocks and Investing
Stocks and Investing
Tue, February 21, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Jeffrey Silber Maintained (AMN) at Buy with Decreased Target to $109 on, Feb 21st, 2023
Jeffrey Silber of BMO Capital, Maintained "AMN Healthcare Services, Inc." (AMN) at Buy with Decreased Target from $130 to $109 on, Feb 21st, 2023.
Jeffrey has made no other calls on AMN in the last 4 months.
There are 3 other peers that have a rating on AMN. Out of the 3 peers that are also analyzing AMN, 1 agrees with Jeffrey's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Mark Marcon of "Baird" Maintained at Hold with Decreased Target to $111 on, Friday, February 17th, 2023
These are the ratings of the 2 analyists that currently disagree with Jeffrey
- Jonathan Yong of "Credit Suisse" Reiterated at Buy and Held Target at $147 on, Friday, February 17th, 2023
- Bill Sutherland of "Benchmark" Reiterated at Strong Buy and Held Target at $148 on, Monday, February 13th, 2023
Contributing Sources